Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 22, 2021
Proposing a surgical algorithm for graduated orbital decompression in patients with Graves' orbitopathyKerstin Stähr, Anke Daser, Michael Oeverhaus, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 2, 2020
Bony Orbital Decompression in Patients with High Myopia and PseudoexophthalmosAnke Daser, Stefan Mattheis, Kerstin Stähr, et al.
Frontiers in Endocrinology|April 21, 2023
Influence of biological sex, age and smoking on Graves' orbitopathy - a ten-year tertiary referral center analysisMichael Oeverhaus, Luisa Winkler, Kerstin Stähr, et al.
Ophthalmic Plastic and Reconstructive Surgery|February 15, 2021
Risk Factors for New Onset Diplopia After Graduated Orbital DecompressionKerstin Stähr, Anja Eckstein, Maren Buschmeier, et al.
Frontiers in Endocrinology|March 16, 2026
Maraviroc attenuates orbital remodeling, inflammation, and lipid dysregulation in a murine model of thyroid eye disease associated with Graves' diseaseFahimeh Hashemi Arani, Anne Gulbins, Mareike Horstmann, et al.
Endocrinology|December 8, 2022
Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' OrbitopathyGina-Eva Görtz, Svenja Philipp, Kirsten Bruderek, et al.
Frontiers in Endocrinology|October 9, 2023
Potential involvement of the bone marrow in experimental Graves' disease and thyroid eye diseaseAnne Gulbins, Mareike Horstmann, Simone Keitsch, et al.
Frontiers in Endocrinology|July 12, 2023
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye diseaseAnne Gulbins, Mareike Horstmann, Anke Daser, et al.
Pageof 2